Anti-FRS1L/ FRRS1L/ C9orf4 monoclonal antibody

Anti-FRS1L/ FRRS1L/ C9orf4 antibody for FACS & in-vivo assay

Target products collectionGo to FRRS1L/FRRS1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0453-Ab-1/ GM-Tg-hg-MP0453-Ab-2Anti-Human FRRS1L monoclonal antibodyHuman
GM-Tg-rg-MP0453-Ab-1/ GM-Tg-rg-MP0453-Ab-2Anti-Rat FRRS1L monoclonal antibodyRat
GM-Tg-mg-MP0453-Ab-1/ GM-Tg-mg-MP0453-Ab-2Anti-Mouse FRRS1L monoclonal antibodyMouse
GM-Tg-cynog-MP0453-Ab-1/ GM-Tg-cynog-MP0453-Ab-2Anti-Cynomolgus/ Rhesus macaque FRRS1L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0453-Ab-1/ GM-Tg-felg-MP0453-Ab-2Anti-Feline FRRS1L monoclonal antibodyFeline
GM-Tg-cang-MP0453-Ab-1/ GM-Tg-cang-MP0453-Ab-2Anti-Canine FRRS1L monoclonal antibodyCanine
GM-Tg-bovg-MP0453-Ab-1/ GM-Tg-bovg-MP0453-Ab-2Anti-Bovine FRRS1L monoclonal antibodyBovine
GM-Tg-equg-MP0453-Ab-1/ GM-Tg-equg-MP0453-Ab-2Anti-Equine FRRS1L monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0453-Ab-1/ GM-Tg-hg-MP0453-Ab-2; GM-Tg-rg-MP0453-Ab-1/ GM-Tg-rg-MP0453-Ab-2;
GM-Tg-mg-MP0453-Ab-1/ GM-Tg-mg-MP0453-Ab-2; GM-Tg-cynog-MP0453-Ab-1/ GM-Tg-cynog-MP0453-Ab-2;
GM-Tg-felg-MP0453-Ab-1/ GM-Tg-felg-MP0453-Ab-2; GM-Tg-cang-MP0453-Ab-1/ GM-Tg-cang-MP0453-Ab-2;
GM-Tg-bovg-MP0453-Ab-1/ GM-Tg-bovg-MP0453-Ab-2; GM-Tg-equg-MP0453-Ab-1/ GM-Tg-equg-MP0453-Ab-2
Products NameAnti-FRRS1L monoclonal antibody
Formatmab
Target NameFRRS1L
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FRRS1L benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FRS1L/ FRRS1L/ C9orf4 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004701mouse Frrs1l Lentivirus plasmid
    ORF Viral VectorvGMLPm004701mouse Frrs1l Lentivirus particle


    Target information

    Target IDGM-MP0453
    Target NameFRRS1L
    Gene ID23732,230235,366376,710212,612466,101089656,538492,100059085
    Gene Symbol and Synonyms6430704M03Rik,C11H9orf4,C8H9orf4,C9orf4,CG-6,CG6,DEE37,EIEE37,Epb4.1l4b,FRRS1L
    Uniprot AccessionQ9P0K9,D3ZE85
    Uniprot Entry NameFRS1L_HUMAN,FRS1L_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000260230
    Target ClassificationN/A

    The target: FRRS1L, gene name: FRRS1L, also named as C9orf4, CG-6, CG6, EIEE37. This gene encodes a component of the outer-core of an alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor protein in the brain. The encoded protein is thought to interact with inner-core components of the receptor, and play a role in the modulation of glutamate signaling. Mutations in this gene are associated with early infantile epileptic encephalopathy 37. [provided by RefSeq, Jul 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.